0000950103-21-004063.txt : 20210315 0000950103-21-004063.hdr.sgml : 20210315 20210315215435 ACCESSION NUMBER: 0000950103-21-004063 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210315 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van de Stolpe Onno CENTRAL INDEX KEY: 0001849787 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40211 FILM NUMBER: 21743472 MAIL ADDRESS: STREET 1: JOHANNES VERMEERPLEIN 9 CITY: AMSTERDAM, STATE: P7 ZIP: 1071 DV ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: European Biotech Acquisition Corp. CENTRAL INDEX KEY: 0001841258 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: JOHANNES VERMEERPLEIN 9 1071 DV CITY: AMSTERDAM STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0) 20 664 55 00 MAIL ADDRESS: STREET 1: JOHANNES VERMEERPLEIN 9 1071 DV CITY: AMSTERDAM STATE: P7 ZIP: 00000 3 1 dp147782_3-van.xml FORM 3 X0206 3 2021-03-15 0 0001841258 European Biotech Acquisition Corp. EBAC 0001849787 van de Stolpe Onno C/O EUROPEAN BIOTECH ACQUISITION CORP. JOHANNES VERMEERPLEIN 9 AMSTERDAM, P7 1071 DV NETHERLANDS 1 0 0 0 Class B ordinary shares Class A ordinary shares 25000 D As described in the issuer's registration statement on Form S-1 (File No. 333-253220) (the "Registration Statement") under the heading "Description of Securities - Founder Shares", the Class B ordinary shares will automatically convert into Class A ordinary shares on a one-for-one basis on the first business day following the consummation of the issuer's initial business combination, subject to adjustment as described in the Registration Statement. The Class B ordinary shares have no expiration date. Exhibit List - Exhibit 24.1 - Power of Attorney /s/ Gisela Wolf as attorney-in-fact for Onno van de Stolpe 2021-03-15 EX-24.1 2 dp147782_ex2401.htm EXHIBIT 24.1

Exhibit 24.1

Power of Attorney

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each and any of Gisela Wolf its true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to:

1. Sign any and all instruments, certificates and documents appropriate or required to be executed on behalf of the undersigned pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any and all regulations promulgated thereunder (including, without limitation, any Joint Filing Agreement with respect thereto), and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission (the “SEC”), and with any other entity when and if such is mandated by the Exchange Act or by the Bylaws of the Financial Industry Regulatory Authority;

2. prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications thereto) with respect to obtaining EDGAR codes, with the SEC;

3. seek or obtain, as the representative of the undersigned and on behalf of the undersigned, information on transactions in the securities of European Biotech Acquisition Corp., from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such attorneys-in-fact and the undersigned approves and ratifies any such release of information; and

4. perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

1. this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorneys-in-fact without independent verification of such information;

2. any documents prepared and/or executed by such attorneys-in-fact on behalf of any of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;

3. neither the Company nor such attorneys-in-fact assumes (a) any liability for responsibility to comply with the requirements of the Exchange Act for any of the undersigned, (b) any liability for any failure to comply with such requirements for any of the undersigned, or (c) any obligation or liability for profit disgorgement under Section 16(b) of the Exchange Act for any of the undersigned; and

4. this Power of Attorney does not relieve any of the undersigned from responsibility for compliance with the undersigned’s obligations under the Exchange Act, including without limitation the reporting requirements under Sections 13 and 16 of the Exchange Act.

The undersigned hereby gives and grants the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, with full power of substitution and revocation, hereby ratifying all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Power of Attorney. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorneys-in-fact.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 2nd day of March, 2021

	/s/ Onno van de Stolpe
	Name: Onno van de Stolpe

[Signature page to Power of Attorney]